Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
Nature Medicine2011Vol. 18(1), pp. 153–158
Citations Over TimeTop 1% of 2011 papers
Mali Jiang, Jiawei Wang, Jinrong Fu, Lin Du, Hyunkyung Jeong, Tim West, Lan Xiang, Peng Qi, Zhipeng Hou, Huan Cai, Tamara Seredenina, Nicolas Arbez, Shanshan Zhu, Katherine Sommers, Jennifer Qian, Jiangyang Zhang, Susumu Mori, X. William Yang, Kellie L. Tamashiro, Susan Aja, Timothy H. Moran, Ruth Luthi‐Carter, Bronwen Martin, Stuart Maudsley, Mark P. Mattson, Robert H. Cichewicz, Christopher A. Ross, David M. Holtzman, Dimitri Krainc, Wenzhen Duan
Related Papers
- → Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington’s disease(2007)112 cited
- → Impaired mitochondrial trafficking in Huntington's disease(2009)67 cited
- → Recent Trends in Detection of Huntingtin and Preclinical Models of Huntington’s Disease(2014)5 cited
- → Inhibition of caspase-6: A potential therapy for Huntington’s disease(2008)
- Assessments of potential interactions of huntingtin-associated-protein-1 in the R6/2 mouse model of Huntington's disease(2004)